These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18339945)

  • 21. Is it wise to leave science to big business?
    Radcliffe M
    Nurs Times; 2005 Mar 22-28; 101(12):156. PubMed ID: 15822719
    [No Abstract]   [Full Text] [Related]  

  • 22. German science reinvigorated.
    Nat Cell Biol; 2008 Jan; 10(1):1. PubMed ID: 18172422
    [No Abstract]   [Full Text] [Related]  

  • 23. Restrictions on business relationships with industries, and their unintended adverse consequences.
    Sataloff RT
    Ear Nose Throat J; 2009 May; 88(5):904-8. PubMed ID: 19444783
    [No Abstract]   [Full Text] [Related]  

  • 24. The mortality of companies.
    Daepp MI; Hamilton MJ; West GB; Bettencourt LM
    J R Soc Interface; 2015 May; 12(106):. PubMed ID: 25833247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethics. Private money, public disclosure.
    Kaiser J
    Science; 2009 Jul; 325(5936):28-30. PubMed ID: 19574366
    [No Abstract]   [Full Text] [Related]  

  • 26. Public health. Public-private partnerships and scientific imperialism.
    Tucker TJ; Makgoba MW
    Science; 2008 May; 320(5879):1016-7. PubMed ID: 18497279
    [No Abstract]   [Full Text] [Related]  

  • 27. Step change in safe harbors: public-private partnerships.
    Curt G
    Oncologist; 2009 Apr; 14(4):308-10. PubMed ID: 19365097
    [No Abstract]   [Full Text] [Related]  

  • 28. Translational research in Berlin hits a roadblock.
    Abbott A
    Nature; 2009 Jan; 457(7228):362-3. PubMed ID: 19158751
    [No Abstract]   [Full Text] [Related]  

  • 29. Public biotech 2007--the numbers.
    Lawrence S; Lähteenmäki R
    Nat Biotechnol; 2008 Jul; 26(7):753-62. PubMed ID: 18612294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Industry funding doesn't influence our reports.
    Kava R
    Nature; 2004 Nov; 432(7013):15. PubMed ID: 15525956
    [No Abstract]   [Full Text] [Related]  

  • 31. Alcohol research and the alcoholic beverage industry: issues, concerns and conflicts of interest.
    Babor TF
    Addiction; 2009 Feb; 104 Suppl 1():34-47. PubMed ID: 19133913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
    Gruber AC
    Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The missing link.
    Gannon F
    EMBO Rep; 2008 Sep; 9(9):819. PubMed ID: 18762770
    [No Abstract]   [Full Text] [Related]  

  • 34. Business on hope: a case study on private cord blood stem cell banking.
    Kiatpongsan S
    J Med Assoc Thai; 2008 Apr; 91(4):577-80. PubMed ID: 18556871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European funding plan 'unviable'.
    Gilbert N
    Nature; 2008 Dec; 456(7222):551. PubMed ID: 19052588
    [No Abstract]   [Full Text] [Related]  

  • 36. Science policy. Russian expats challenge government's 'disastrous' support for science.
    Allakhverdov A; Pokrovsky V
    Science; 2009 Oct; 326(5951):353. PubMed ID: 19833934
    [No Abstract]   [Full Text] [Related]  

  • 37. Shovel-ready science?
    Gast AP
    Science; 2009 Mar; 323(5922):1646. PubMed ID: 19325081
    [No Abstract]   [Full Text] [Related]  

  • 38. Scripts for science: a new wrinkle on academic ties with industry.
    Hauser SL; Johnston SC
    Ann Neurol; 2008 Oct; 64(4):A13-5. PubMed ID: 18991356
    [No Abstract]   [Full Text] [Related]  

  • 39. Income of US veterinarians, 2007.
    Shepherd AJ
    J Am Vet Med Assoc; 2009 Mar; 234(6):754-6. PubMed ID: 19284338
    [No Abstract]   [Full Text] [Related]  

  • 40. Addressing the decline in NIH pain research funding.
    Max MB
    J Pain; 2008 Dec; 9(12):1074-6. PubMed ID: 19038769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.